“ What’s in the Pipeline?” - Fairly basic article but provides general insight into potential DMD cures - Summit get a mention ,not that many players in this space - SMTC1100 i think the only treatment that can potentially treat 100% of DMD patients but that detail overlooked ! No idea what circulation this journal might have ?? http://factbasedhealth.com/tag/duchenne-muscular-dystrophy-dmd/ Good luck everyone !
It was a purchase of 12,000 (11.02)
Just for the record it was my purchase at 11.02 for 12,000 at 8.944 through Barclays it was not a sale.
Hope this keeps going up. Big oaks from little acorns grow.
Bought 91000 more shares tonight. Since the 13p days we have over £20,000,000 in the bank and received a £1,000,000 grant and are nearer to POC therefor the company is much better placed than ever.The sp will reflect this in the future so hold tight and reap the rewards.
Hold your nerve
It is frustrating that this share tends to tick up then slide back down again. I must admit that I didn't think that we would see sub 10. I wish I had more available funds but I've enough on these. Good luck all holders and thanks for the great posts on this board.
RE: Phase1b results
Hope they don’t mind me sharing again ! Think we all endorse the sentiments expressed ! One parent comment on the phase1b trial “Our son Christopher has just completed Phase 1b today at Heartlands Hospital. He came through it very well and we know what you are going through. Fingers crossed for Phase 2” https://www.facebook.com/photo.php?fbid=10153855376270405&set=gm.828918837124338&type=1&theater Good luck everyone !
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.